Market Size of Europe Lab-on-a-chip and Microarrays (Biochip) Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Historical Data Period | 2019 - 2022 |
| CAGR | 11.13 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Europe Lab-on-a-Chip and Microarrays (Biochip) Market Analysis
Europe Lab-on-a-Chip and Microarrays (Biochip) Market are expected to witness a high CAGR growth during the forecast period, owing to the rising burden of chronic diseases, increasing applications of proteomics and genomics, and increasing demand for point of care testing. According to the Cancer Atlas, in 2018, approximately 3.9 million new cases of cancer and almost 1.9 million deaths were registered in Europe. Protein microarrays are one of the advancing tools which hold a promising future in cancer proteomics research. Therefore, these factors are expected to fuel market growth in the forecast period.
Europe Lab-on-a-Chip and Microarrays (Biochip) Industry Segmentation
As per the scope of the report, a biochip is a collection of miniaturized test sites (microarrays) arranged on a solid substrate that permits many tests to be performed at the same time, to achieve higher throughput and speed. Europe Lab-on-a-Chip and Microarrays (Biochip) Market are segmented By Type, By Product, By Application, By End User and Country.
| By Type | |
| Lab-on-a-Chip | |
| Microarray |
| By Products | |
| Instruments | |
| Reagents & Consumables | |
| Software and Services |
| By Application | |
| Clinical Diagnostics | |
| Drugs Discovery | |
| Genomics and Proteomics | |
| Others |
| By End-User | |
| Biotechnology & Pharmaceutical Companies | |
| Hospitals & Diagnostics Centres | |
| Academic & Research Institute |
| By Country | |
| Germany | |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe |
Europe Lab-on-a-chip and Microarrays (Biochip) Market Size Summary
The Europe Lab-on-a-Chip and Microarrays market is poised for substantial growth, driven by the increasing prevalence of chronic diseases and the expanding applications in proteomics and genomics. The demand for point-of-care testing is also contributing to this upward trend. The market is witnessing advancements in protein microarrays, which are becoming essential tools in cancer proteomics research. This growth is further supported by the significant burden of cardiovascular diseases, which account for a large percentage of mortality in Europe, highlighting the need for innovative diagnostic solutions. Microarrays, in particular, are gaining traction due to their capability to profile lncRNA and mRNA expression, offering valuable insights into disease mechanisms.
Key industry players such as Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, GE Healthcare, and ThermoFisher Scientific are actively contributing to the market's expansion. The approval of novel technologies, like the CE Mark for Immunohematology Microarray by Quotient Limited, underscores the ongoing innovation and regulatory support in the sector. These developments are expected to enhance the market's growth trajectory, as they address the critical need for advanced diagnostic tools in Europe. The combination of technological advancements and the rising demand for efficient testing solutions is set to propel the Lab-on-a-Chip and Microarrays market forward during the forecast period.
Europe Lab-on-a-chip and Microarrays (Biochip) Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Burden of Chronic Diseases due to Lifestyle Changes
-
1.2.2 Increasing Demand for Point-of-Care-Testing
-
1.2.3 Increasing Applications of Proteomics and Genomics in Cancer Research
-
-
1.3 Market Restraints
-
1.3.1 Design Constraints of Lab-on-chip Technology
-
1.3.2 Availability of Alternative Technologies
-
-
1.4 Porter's Five Force Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 By Type
-
2.1.1 Lab-on-a-Chip
-
2.1.2 Microarray
-
-
2.2 By Products
-
2.2.1 Instruments
-
2.2.2 Reagents & Consumables
-
2.2.3 Software and Services
-
-
2.3 By Application
-
2.3.1 Clinical Diagnostics
-
2.3.2 Drugs Discovery
-
2.3.3 Genomics and Proteomics
-
2.3.4 Others
-
-
2.4 By End-User
-
2.4.1 Biotechnology & Pharmaceutical Companies
-
2.4.2 Hospitals & Diagnostics Centres
-
2.4.3 Academic & Research Institute
-
-
2.5 By Country
-
2.5.1 Germany
-
2.5.2 United Kingdom
-
2.5.3 France
-
2.5.4 Italy
-
2.5.5 Spain
-
2.5.6 Rest of Europe
-
-
Europe Lab-on-a-chip and Microarrays (Biochip) Market Size FAQs
What is the current Europe Lab-on-a-chip and Microarrays (Biochip) Market size?
The Europe Lab-on-a-chip and Microarrays (Biochip) Market is projected to register a CAGR of 11.13% during the forecast period (2024-2029)
Who are the key players in Europe Lab-on-a-chip and Microarrays (Biochip) Market?
ThermoFisher Scientific, Agilent Technologies, Bio-Rad Laboratories, Abbott Laboratories and Perkin Elmer Inc. are the major companies operating in the Europe Lab-on-a-chip and Microarrays (Biochip) Market.
